U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C42H83NO4
Molecular Weight 666.1127
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of N-(2'-(S)-hydroxyhexacosanoyl)-D-erythro-C16-sphingosine

SMILES

CCCCCCCCCCCCCCCCCCCCCCCC[C@H](O)C(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCC

InChI

InChIKey=DALDXDWDMQKPSM-QJYCDPGTSA-N
InChI=1S/C42H83NO4/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-23-24-25-27-29-31-33-35-37-41(46)42(47)43-39(38-44)40(45)36-34-32-30-28-26-14-12-10-8-6-4-2/h34,36,39-41,44-46H,3-33,35,37-38H2,1-2H3,(H,43,47)/b36-34+/t39-,40+,41-/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
N-(2'-(S)-hydroxyhexacosanoyl)-D-erythro-C16-sphingosine
Systematic Name English
C26 (2’(S)-hydroxy) Ceramide (d16:1/26:0)
Preferred Name English
Hexacosanamide, 2-hydroxy-N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-pentadecen-1-yl]-, (2S)-
Systematic Name English
(2S)-2-Hydroxy-N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-pentadecen-1-yl]hexacosanamide
Systematic Name English
Code System Code Type Description
FDA UNII
M528TDY54E
Created by admin on Wed Apr 02 19:43:39 GMT 2025 , Edited by admin on Wed Apr 02 19:43:39 GMT 2025
PRIMARY